Global Spinal Muscular Atrophy (SMA) Treatment Market Growth (Status and Outlook) 2022-2028

January 2022 | 86 pages | ID: G8BC4C73B806EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Spinal Muscular Atrophy (SMA) Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Spinal Muscular Atrophy (SMA) Treatment market size is USD million in 2022 from USD 895.5 million in 2021, with a change of % between 2021 and 2022. The global Spinal Muscular Atrophy (SMA) Treatment market size will reach USD 1492.7 million in 2028, growing at a CAGR of 7.6% over the analysis period.

The United States Spinal Muscular Atrophy (SMA) Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Spinal Muscular Atrophy (SMA) Treatment market, reaching US$ million by the year 2028. As for the Europe Spinal Muscular Atrophy (SMA) Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Spinal Muscular Atrophy (SMA) Treatment players cover Pfizer, Isis Pharmaceuticals, Biogen Idec, and Boehringer Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Spinal Muscular Atrophy (SMA) Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Type I Spinal Muscular Atrophy (SMA)
• Type II Spinal Muscular Atrophy (SMA)
• Type III Spinal Muscular Atrophy (SMA)

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Pfizer
• Isis Pharmaceuticals
• Biogen Idec
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• Regeneron Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size 2017-2028
  2.1.2 Spinal Muscular Atrophy (SMA) Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Spinal Muscular Atrophy (SMA) Treatment Segment by Type
  2.2.1 Type I Spinal Muscular Atrophy (SMA)
  2.2.2 Type II Spinal Muscular Atrophy (SMA)
  2.2.3 Type III Spinal Muscular Atrophy (SMA)
2.3 Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
  2.3.1 Spinal Muscular Atrophy (SMA) Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2022)
2.4 Spinal Muscular Atrophy (SMA) Treatment Segment by Application
  2.4.1 Hospitals
  2.4.2 Ambulatory Surgical Centers
  2.4.3 Diagnostic Centers
  2.4.4 Others
2.5 Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
  2.5.1 Spinal Muscular Atrophy (SMA) Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2022)

3 SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET SIZE BY PLAYER

3.1 Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Players
  3.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Players (2020-2022)
  3.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Spinal Muscular Atrophy (SMA) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SPINAL MUSCULAR ATROPHY (SMA) TREATMENT BY REGIONS

4.1 Spinal Muscular Atrophy (SMA) Treatment Market Size by Regions (2017-2022)
4.2 Americas Spinal Muscular Atrophy (SMA) Treatment Market Size Growth (2017-2022)
4.3 APAC Spinal Muscular Atrophy (SMA) Treatment Market Size Growth (2017-2022)
4.4 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022)
5.2 Americas Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
5.3 Americas Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2017-2022)
6.2 APAC Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
6.3 APAC Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Spinal Muscular Atrophy (SMA) Treatment by Country (2017-2022)
7.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
7.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment by Region (2017-2022)
8.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET FORECAST

10.1 Global Spinal Muscular Atrophy (SMA) Treatment Forecast by Regions (2023-2028)
  10.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Forecast by Regions (2023-2028)
  10.1.2 Americas Spinal Muscular Atrophy (SMA) Treatment Forecast
  10.1.3 APAC Spinal Muscular Atrophy (SMA) Treatment Forecast
  10.1.4 Europe Spinal Muscular Atrophy (SMA) Treatment Forecast
  10.1.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Forecast
10.2 Americas Spinal Muscular Atrophy (SMA) Treatment Forecast by Country (2023-2028)
  10.2.1 United States Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.2.2 Canada Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.2.3 Mexico Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.2.4 Brazil Spinal Muscular Atrophy (SMA) Treatment Market Forecast
10.3 APAC Spinal Muscular Atrophy (SMA) Treatment Forecast by Region (2023-2028)
  10.3.1 China Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.3.2 Japan Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.3.3 Korea Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.3.4 Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.3.5 India Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.3.6 Australia Spinal Muscular Atrophy (SMA) Treatment Market Forecast
10.4 Europe Spinal Muscular Atrophy (SMA) Treatment Forecast by Country (2023-2028)
  10.4.1 Germany Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.4.2 France Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.4.3 UK Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.4.4 Italy Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.4.5 Russia Spinal Muscular Atrophy (SMA) Treatment Market Forecast
10.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Forecast by Region (2023-2028)
  10.5.1 Egypt Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.5.2 South Africa Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.5.3 Israel Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.5.4 Turkey Spinal Muscular Atrophy (SMA) Treatment Market Forecast
  10.5.5 GCC Countries Spinal Muscular Atrophy (SMA) Treatment Market Forecast
10.6 Global Spinal Muscular Atrophy (SMA) Treatment Forecast by Type (2023-2028)
10.7 Global Spinal Muscular Atrophy (SMA) Treatment Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Spinal Muscular Atrophy (SMA) Treatment Product Offered
  11.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Isis Pharmaceuticals
  11.2.1 Isis Pharmaceuticals Company Information
  11.2.2 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Offered
  11.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Isis Pharmaceuticals Main Business Overview
  11.2.5 Isis Pharmaceuticals Latest Developments
11.3 Biogen Idec
  11.3.1 Biogen Idec Company Information
  11.3.2 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product Offered
  11.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Biogen Idec Main Business Overview
  11.3.5 Biogen Idec Latest Developments
11.4 Boehringer Ingelheim
  11.4.1 Boehringer Ingelheim Company Information
  11.4.2 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product Offered
  11.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 Boehringer Ingelheim Main Business Overview
  11.4.5 Boehringer Ingelheim Latest Developments
11.5 F. Hoffmann-La Roche
  11.5.1 F. Hoffmann-La Roche Company Information
  11.5.2 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product Offered
  11.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 F. Hoffmann-La Roche Main Business Overview
  11.5.5 F. Hoffmann-La Roche Latest Developments
11.6 Regeneron Pharmaceuticals
  11.6.1 Regeneron Pharmaceuticals Company Information
  11.6.2 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Offered
  11.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 Regeneron Pharmaceuticals Main Business Overview
  11.6.5 Regeneron Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Spinal Muscular Atrophy (SMA) Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Type I Spinal Muscular Atrophy (SMA)
Table 3. Major Players of Type II Spinal Muscular Atrophy (SMA)
Table 4. Major Players of Type III Spinal Muscular Atrophy (SMA)
Table 5. Spinal Muscular Atrophy (SMA) Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2022)
Table 8. Spinal Muscular Atrophy (SMA) Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2022)
Table 11. Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Player (2020-2022)
Table 13. Spinal Muscular Atrophy (SMA) Treatment Key Players Head office and Products Offered
Table 14. Spinal Muscular Atrophy (SMA) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Regions (2017-2022)
Table 19. Americas Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Country (2017-2022)
Table 21. Americas Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2022)
Table 23. Americas Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2022)
Table 25. APAC Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Region (2017-2022)
Table 27. APAC Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2022)
Table 29. APAC Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2022)
Table 31. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Country (2017-2022)
Table 33. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2022)
Table 35. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Spinal Muscular Atrophy (SMA) Treatment
Table 44. Key Market Challenges & Risks of Spinal Muscular Atrophy (SMA) Treatment
Table 45. Key Industry Trends of Spinal Muscular Atrophy (SMA) Treatment
Table 46. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 52. Pfizer Details, Company Type, Spinal Muscular Atrophy (SMA) Treatment Area Served and Its Competitors
Table 53. Pfizer Spinal Muscular Atrophy (SMA) Treatment Product Offered
Table 54. Pfizer Spinal Muscular Atrophy (SMA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Isis Pharmaceuticals Details, Company Type, Spinal Muscular Atrophy (SMA) Treatment Area Served and Its Competitors
Table 58. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Offered
Table 59. Isis Pharmaceuticals Main Business
Table 60. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Isis Pharmaceuticals Latest Developments
Table 62. Biogen Idec Details, Company Type, Spinal Muscular Atrophy (SMA) Treatment Area Served and Its Competitors
Table 63. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product Offered
Table 64. Biogen Idec Main Business
Table 65. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Biogen Idec Latest Developments
Table 67. Boehringer Ingelheim Details, Company Type, Spinal Muscular Atrophy (SMA) Treatment Area Served and Its Competitors
Table 68. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product Offered
Table 69. Boehringer Ingelheim Main Business
Table 70. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Boehringer Ingelheim Latest Developments
Table 72. F. Hoffmann-La Roche Details, Company Type, Spinal Muscular Atrophy (SMA) Treatment Area Served and Its Competitors
Table 73. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product Offered
Table 74. F. Hoffmann-La Roche Main Business
Table 75. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. F. Hoffmann-La Roche Latest Developments
Table 77. Regeneron Pharmaceuticals Details, Company Type, Spinal Muscular Atrophy (SMA) Treatment Area Served and Its Competitors
Table 78. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Offered
Table 79. Regeneron Pharmaceuticals Main Business
Table 80. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Regeneron Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Spinal Muscular Atrophy (SMA) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type in 2021
Figure 7. Spinal Muscular Atrophy (SMA) Treatment in Hospitals
Figure 8. Global Spinal Muscular Atrophy (SMA) Treatment Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Spinal Muscular Atrophy (SMA) Treatment in Ambulatory Surgical Centers
Figure 10. Global Spinal Muscular Atrophy (SMA) Treatment Market: Ambulatory Surgical Centers (2017-2022) & ($ Millions)
Figure 11. Spinal Muscular Atrophy (SMA) Treatment in Diagnostic Centers
Figure 12. Global Spinal Muscular Atrophy (SMA) Treatment Market: Diagnostic Centers (2017-2022) & ($ Millions)
Figure 13. Spinal Muscular Atrophy (SMA) Treatment in Others
Figure 14. Global Spinal Muscular Atrophy (SMA) Treatment Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application in 2021
Figure 16. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Player in 2021
Figure 17. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Spinal Muscular Atrophy (SMA) Treatment Market Size 2017-2022 ($ Millions)
Figure 19. APAC Spinal Muscular Atrophy (SMA) Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size 2017-2022 ($ Millions)
Figure 22. Americas Spinal Muscular Atrophy (SMA) Treatment Value Market Share by Country in 2021
Figure 23. Americas Spinal Muscular Atrophy (SMA) Treatment Consumption Market Share by Type in 2021
Figure 24. Americas Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application in 2021
Figure 25. United States Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Region in 2021
Figure 30. APAC Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application in 2021
Figure 31. China Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Country in 2021
Figure 38. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type in 2021
Figure 39. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application in 2021
Figure 40. Germany Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application in 2021
Figure 48. Egypt Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Spinal Muscular Atrophy (SMA) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 54. APAC Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 55. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 57. United States Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Canada Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 61. China Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Japan Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 63. Korea Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 65. India Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 66. Australia Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 67. Germany Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 68. France Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 69. UK Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Italy Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Russia Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 72. Spain Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 75. Israel Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Spinal Muscular Atrophy (SMA) Treatment Market Size 2023-2028 ($ Millions)